Health Condition 1: T300- Burn of unspecified body region, unspecified degree Health Condition 2: L984- Non-pressure chronic ulcer of skin, not elsewhere classified Health Condition 3: E116- Type 2 diabetes mellitus with other specified complications
Conditions
Interventions
Intervention1: Topical Application Of Autologous Platelet Rich Plasma In Wound Bed During Split Skin Graft: Bioplogical Agent-Autologous Platelet Rich Plasma
Route Of Application-Topical Before Skin G
Sponsors
Vinayaka Mission Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Acute And Chronic Traumatic, Post Burn Wounds. Patients With Co-Morbidities Like Diabetes And Hypertension. Patients On Aspirin Analogues.
Exclusion criteria
Exclusion criteria: Age Less Than 18years And More Than 75years Those With Coagulation Disorders And Malignancy.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary Objective Parameters For Assessment Of Efficacy Of Platelet Rich Plasma Are Hematoma with Significant Graft Loss, Scar HypertrophyTimepoint: My Duration Of Study Will Be 18 Months | — |
Primary
| Measure | Time frame |
|---|---|
| Objective Parameters For Assessment Of Efficacy Of Platelet Rich Plasma Are Instant Adhesion, Graft Edema, Discharge from Graft Site, Hematoma.Timepoint: My Duration Of Study Will Be 18 Months | — |
Countries
India
Contacts
Public ContactDr Karthik N
Vinayaka Mission Medical College
Outcome results
None listed